Cherwell increases commitment to pharmaceutical microbiology in Republic of Ireland
Ritchie Mooney appointed as Sales Specialist, based in the Republic of Ireland.
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, are continuing their drive to improve support for pharmaceutical microbiology in the Republic of Ireland. As part of this initiative, Cherwell has appointed Ritchie Mooney as Sales Specialist, based in the Republic of Ireland. To further establish their commitment to the Irish market, Cherwell will also be supporting and attending the Pharmig conference on the 18 May in Cork, Ireland.
Prior to joining Cherwell Laboratories, Ritchie has worked for both manufacturers and distributors in the Life Science and associated industries for almost 20 years. During his time with Veltek Associates in particular, Ritchie acquired a good knowledge of Environmental Monitoring sampling and equipment, along with fogging systems and sterile disposable products for cleaning and disinfection purposes. Commenting on his new position at Cherwell, Ritchie said: “I am excited to be joining Cherwell and I am really looking forward to helping customers in Ireland with our Redipor Prepared Media in relation to various applications, such as environmental monitoring, product sterility testing, operator validation and process validation, amongst others.”
Andrew Barrow, Sales Manager of Cherwell, commented: “With Cherwell now shipping Redipor product directly to customers in the Republic of Ireland, we welcome Ritchie to the team. His previous experience within the industry; good understanding and appreciation of GMP and sterile production; along with his knowledge of the latest industry guidelines; means that Ritchie is able to fully understand and help us satisfy customer needs.”
Ritchie Mooney and Andrew Barrow will both be representing Cherwell at the Pharmig conference held on the 18 May at Fota Island Hotel, Cork. They will be on hand to offer practical advice on Cherwell’s products and their applications within environmental monitoring, sterility testing of products, and process validation. The event will highlight Current Hot Topics in Pharmaceutical Microbiology. Topics covered include: data integrity and new expectations; EM incubation strategies; contamination control and regulatory requirements. Also, at the same venue, Pharmig is hosting a second event on 19 May Focusing on Control of Pharmaceutical Water Systems Topics will include, Annex 1 and ISO 14644 updates; data integrity and disinfectant efficacy testing.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance